Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Pancreatic Neoplasms × Tadalafil × Clear all

Phase

Phase 2 2 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Neoplasms 1 Head and Neck Neoplasms 1 Glioblastoma 1 Astrocytoma 1 Adenocarcinoma 1 Abdominal Cancer 1

Interventions

Gemcitabine 169 130-nm albumin-bound paclitaxel 54 Albumin-Bound Paclitaxel 42 Oxaliplatin 32 Fluorouracil 31 pembrolizumab 30 Capecitabine 30 Leucovorin 27 Irinotecan 27 Radiotherapy 25 Nivolumab 22 Erlotinib Hydrochloride 21 Taxes 19 Cisplatin 18 Bevacizumab 15 Specimen Handling 11 Radiosurgery 11 Magnetic Resonance Spectroscopy 11 Cyclophosphamide 11 Ipilimumab 10 Drug Therapy 10 Carboplatin 10 Paclitaxel 9 Docetaxel 9 Cetuximab 9 Biopsy 9 trametinib 8 olaparib 8 Sorafenib 8 poly ICLC 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01903083 2018-02-01

CRIT

Providence Health & Services

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡